E-cigarette users have 30% higher risk for chronic lung diseases, study finds
E-cigarette users have a roughly 30% higher risk for developing respiratory illness, such as chronic obstructive pulmonary disease, emphysema, chronic bronchitis and asthma than non-users, according to a study in JAMA. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 12, 2020 Category: Consumer Health News Source Type: news
Redwood City medical device maker Pulmonx tops IPO targets, raises $190M
A day after boosting its IPO targets by 69%, medical device maker Pulmonx Corp. topped them in an offering that raised $190 million.
The Redwood City company, which makes minimally invasive medical devices for emphysema, sold 10 million shares at $19, above its revised range of between $17 and $18.
Along with a $450 million Wall Street debut on Thursday by Menlo Park-based "blank check" company Altimeter Growth Corp., there have now been 36 IPOs in 2020 by Bay Area companies.That ties last year's… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 1, 2020 Category: Pharmaceuticals Authors: Cromwell Schubarth Source Type: news
Redwood City medical device maker Pulmonx boosts IPO targets by 69%
Pulmonx Corp., which makes minimally invasive medical devices for emphysema, on Wednesday said it hopes to raise about $210 million in its upcoming IPO — a boost of about 69% over previous targets.
The Redwood City company now plans to sell 10 million shares for between $17 and $18 a share, with about 1.5 million more shares set aside for underwriters. It previously planned to sell 6.7 million shares for between $14 and $16 each, with 1 million set aside for underwriters.
This is Pulmonx's second… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 30, 2020 Category: Biotechnology Authors: Cromwell Schubarth Source Type: news
Redwood City medical device maker Pulmonx sets targets for $123M IPO
Pulmonx Corp., which makes minimally invasive medical devices for emphysema, set price targets Thursday for an IPO in which it hopes to raise up to $123 million.
This is the Redwood City company's second attempt this year at going public after shelving an earlier plan to raise up to $86 million. It withdrew that filing after raising $66 million privately in May.
The 202-employee company expects to list on the Nasdaq exchange as “LUNG.” It is offering 6.7 million shares for between $14 and $16… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Cromwell Schubarth Source Type: news
Bronchoscopic Lung-Volume Reduction Can Help Some With Severe Emphysema Bronchoscopic Lung-Volume Reduction Can Help Some With Severe Emphysema
Bronchoscopic lung-volume reduction achieved by endobronchial valve placement can be an effective alternative to open lung-volume reduction surgery for relieving symptoms in patients with severe emphysema and air trapping, according to a new review.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 8, 2020 Category: Surgery Tags: Pulmonary Medicine News Source Type: news
How to Make Homemade Face Masks More Effective —and How to Wear Them Right
Five months after coronavirus took root in the U.S., face masks remain one of the most controversial and confusing parts of the pandemic.
Changing public-health messaging hasn’t helped. In March, when personal protective equipment (PPE) was running short, top U.S. public-health officials told Americans that the general public did not need masks because they don’t fully block respiratory particles that spread COVID-19, such as those in a sick person’s cough or sneeze. Most masks are best at preventing particles from getting into the air where others might inhale them, so, at first, the U.S. Centers for Dis...
Source: TIME: Health - August 24, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news
Lung Risk Factors May Boost Hip Fracture Risk in Smokers Lung Risk Factors May Boost Hip Fracture Risk in Smokers
People who smoke may have lung-specific risk factors such as emphysema that increase the risk of hip fracture, according to an observational study.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - August 13, 2020 Category: Orthopaedics Tags: Diabetes & Endocrinology News Source Type: news
A targeted treatment for emphysema?
(Boston Children's Hospital) Emphysema is a progressive, debilitating lung disease in which the lung's breathing sacs, or alveoli, enlarge, get thinner, and eventually are destroyed as the cells die off. It can be fatal, and there is currently no cure. New research at Boston Children's Hospital, using lung cells and mouse models of emphysema, offers hope in the form of a small, engineered peptide molecule called PR1P. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 4, 2020 Category: International Medicine & Public Health Source Type: news
Combined Pulmonary Fibrosis and Emphysema Combined Pulmonary Fibrosis and Emphysema
What do we currently know about combined pulmonary fibrosis and emphysema? Learn more about the features of this condition and explore treatment options.Seminars in Respiratory and Critical Care Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 3, 2020 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news
CT illuminates why nonsmokers get COPD
A study using CT to image the lungs of patients has found that people with...Read more on AuntMinnie.comRelated Reading:
Texture analysis could help quantify COPD on CT
AI can accurately quantify emphysema on CT
Should CT be added to criteria for diagnosing COPD?
U.K. group uses math to characterize lung disease on CT
Genetic variation in lung airways elevates risk of COPD (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 10, 2020 Category: Radiology Source Type: news
Pulmonary Rehab Can Help People With COPD, So Why Do So Few Get It?
MONDAY, May 18, 2020 -- Roughly 16 million Americans have chronic obstructive pulmonary disease (COPD), but only a fraction have access to a lifesaving treatment called pulmonary rehabilitation.
COPD is a family of diseases, including emphysema and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 18, 2020 Category: General Medicine Source Type: news
Medtech in a Minute: COVID-19 Fraud, a Virtual AFib Trial, and More
FDA Cracks Down on Fraudulent COVID-19 Tests
The agency revised its earlier policy on COVID-19 antibody tests to cut down on false and inappropriate marketing claims that have cropped up. In March it was critical for FDA to provide regulatory flexibility for serology test developers, given the nature of this public health emergency. But officials said this week that flexibility never meant they would allow fraud.
Â
Now May Not Be the Best Time for an IPO
Pulmonx was poised to go public but the global pandemic forced the company to switch gears. Still, Pulmonx managed to raise $66 million...
Source: MDDI - May 8, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news
Pulmonx Delays IPO and Reels in $66M Financing
Pulmonx has raised $66 million in a financing round despite a lull in procedures and a turbulent economy caused by the negative impact of the novel coronavirus [COVID-19].
The commercial-stage medical device firm, which was on the list of 16 Promising Private Medtech Companies in 2019, developed the Zephyr Valve System, a minimally invasive treatment from patients suffering from emphysema.
The financing round comes a little more than a month after Pulmonx delayed its $86 million IPO.
“We were poised to take the company public,†Pulmonx CEO Glen French told MD+DI. “What ...
Source: MDDI - May 5, 2020 Category: Medical Devices Tags: Implants Business Source Type: news
Coronavirus Fears Have People With Asthma, Emphysema Avoiding the ER
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 21, 2020 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Infections, Pediatrics, Pulmonology, Asthma, News, Source Type: news
